Role of the fibroblast growth factor type 23 in progression of complications and imbalance of calcium-phosphoric metabolism with patients suffering chronic kidney disease
Abstract
The review discusses the role of fibroblast growth factor type 23 (FGF-23) in progression of renal dysfunction and its cardiovascular effects, calcium-phosphorus metabolism in patients with chronic kidney disease. Differences in the FGF-23 effects at predialysis stage of chronic kidney disease, in dialysis patients and renal allograft recipients are analyzed.
Keywords
